Literature DB >> 10801775

Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin.

Y F Liu1, D Dorow, J Marshall.   

Abstract

We previously reported that expression of polyglutamine-expanded huntingtin induces apoptosis via c-Jun amino-terminal kinase (JNK) activation in HN33 cells (Liu, Y. F. (1998) J. Biol. Chem. 273, 28873-28822). Extending this study, we now demonstrate a role of mixed-lineage kinase 2 (MLK2), a JNK activator, in polyglutamine-expanded huntingtin-mediated neuronal toxicity. We find that normal huntingtin interacts with MLK2, whereas the polyglutamine expansion interferes with this interaction. Similar to the expression of polyglutamine-expanded huntingtin, expression of MLK2 also induces JNK activation and apoptosis in HN33 cells. Co-expression of dominant negative MLK2 significantly attenuates neuronal apoptosis induced by the mutated huntingtin. Furthermore, over-expression of the N terminus of normal huntingtin partially rescues the neuronal toxicity induced by MLK2. Our results suggest that activation of MLK2-mediated signaling cascades may be partially involved in neuronal death induced by polyglutamine-expanded huntingtin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801775     DOI: 10.1074/jbc.C000180200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Huntington's disease.

Authors:  S Davies; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

2.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

3.  Synchrotron infrared microspectroscopy detecting the evolution of Huntington's disease neuropathology and suggesting unique correlates of dysfunction in white versus gray brain matter.

Authors:  Markus Bonda; Valérie Perrin; Bertrand Vileno; Heike Runne; Ariane Kretlow; László Forró; Ruth Luthi-Carter; Lisa M Miller; Sylvia Jeney
Journal:  Anal Chem       Date:  2011-09-22       Impact factor: 6.986

4.  Sulforaphane Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity by Activating the Keap1-Nrf2-ARE Pathway and Inhibiting the MAPKs and NF-κB Pathways.

Authors:  Minhee Jang; Ik-Hyun Cho
Journal:  Mol Neurobiol       Date:  2015-06-23       Impact factor: 5.590

5.  Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.

Authors:  Clare M Gladding; Jing Fan; Lily Y J Zhang; Liang Wang; Jian Xu; Edward H Y Li; Paul J Lombroso; Lynn A Raymond
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

6.  Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.

Authors:  Delphine Charvin; Peter Vanhoutte; Christiane Pagès; Emilliana Borrelli; Emiliana Borelli; Jocelyne Caboche
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

7.  Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2.

Authors:  Edoardo Marcora; Katherine Gowan; Jacqueline E Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

Review 8.  Huntingtin associated protein 1 and its functions.

Authors:  Linda Lin-yan Wu; Xin-Fu Zhou
Journal:  Cell Adh Migr       Date:  2009-01-26       Impact factor: 3.405

Review 9.  Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans.

Authors:  J Alex Parker; Sébastien Holbert; Emmanuel Lambert; Salima Abderrahmane; Christian Néri
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 10.  Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis.

Authors:  Andreas Wyttenbach
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.